Duopharma Biotech Berhad (KLSE:DPHARMA)
1.380
+0.010 (0.73%)
At close: Sep 12, 2025
Duopharma Biotech Berhad Revenue
Duopharma Biotech Berhad had revenue of 221.78M MYR in the quarter ending June 30, 2025, with 1.58% growth. This brings the company's revenue in the last twelve months to 886.92M, up 18.57% year-over-year. In the year 2024, Duopharma Biotech Berhad had annual revenue of 813.70M with 15.46% growth.
Revenue (ttm)
886.92M
Revenue Growth
+18.57%
P/S Ratio
1.50
Revenue / Employee
453.21K
Employees
1,957
Market Cap
1.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 813.70M | 108.97M | 15.46% |
Dec 31, 2023 | 704.73M | 8.01M | 1.15% |
Dec 31, 2022 | 696.72M | 57.54M | 9.00% |
Dec 31, 2021 | 639.18M | 69.27M | 12.16% |
Dec 31, 2020 | 569.90M | -6.56M | -1.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Malayan Banking Berhad | 28.41B |
Public Bank Berhad | 14.50B |
CIMB Group Holdings Berhad | 20.75B |
Tenaga Nasional Berhad | 64.76B |
IHH Healthcare Berhad | 24.93B |
Press Metal Aluminium Holdings Berhad | 15.42B |
Celcomdigi Berhad | 12.87B |
Hong Leong Bank Berhad | 6.78B |